(Q33952040)

30 July 2017

1 reference

title

Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence (English)

1 reference

30 July 2017

1 reference

Gallimberti L

1

1 reference

30 July 2017

Spella MR

series ordinal

2

1 reference

30 July 2017

Soncini CA

series ordinal

3

1 reference

30 July 2017

Gessa GL

series ordinal

4

1 reference

30 July 2017

publication date

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

257-262

1 reference

Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Abuse and therapeutic potential of gamma-hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Clonidine blocks acute opiate-withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Another case of gamma hydroxybutyrate (GHB) overdose.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

[Gamma-hydroxybutyric acid--significance for anesthesia and intensive care medicine?]

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Sodium 4-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Gamma-hydroxybutyrate in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

GHB use in South Carolina

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Neurodegeneration, sleep, and cerebral energy metabolism: a testable hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Gamma-hydroxybutyric acid and alcohol-related syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

1 reference

7 January 2021

Gamma-Hydroxybutyrate Treatment of Schizophrenia: A Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Gamma hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Gamma hydroxybutyrate in the monkey: III. Effect of intravenous anticonvulsant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

The ontogeny of GABAergic enhancement of the gamma-hydroxybutyrate model of generalized absence seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

GABAA receptor function in the gamma-hydroxybutyrate model of generalized absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

Effect of acute and chronic anticonvulsant administration on endogenous gamma-hydroxybutyrate in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900089-0

7 January 2021

10.1016/S0741-8329(99)00089-0

Identifiers

DOI

1 reference

30 July 2017

1 reference